Journal of Virology, July 2006, p. 6441-6457, Vol. 80, No. 13
0022-538X/06/$08.00+0 doi:10.1128/JVI.00591-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4+ T Cells
Justin R. Bailey,1,
Ahmad R. Sedaghat,1,
Tara Kieffer,1,
Timothy Brennan,1
Patricia K. Lee,1
Megan Wind-Rotolo,1
Christine M. Haggerty,1
Ashrit R. Kamireddi,1
Yi Liu,1
Jessica Lee,1
Deborah Persaud,2
Joel E. Gallant,1
Joseph Cofrancesco Jr.,1
Thomas C. Quinn,1,3
Claus O. Wilke,4
Stuart C. Ray,1
Janet D. Siliciano,1
Richard E. Nettles,1 and
Robert F. Siliciano1,5*
Departments of Medicine,1
Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205,2
National Institutes of Allergy and Infectious Diseases, NIH, Bethesda, Maryland 20892,3
Section of Integrative Biology, University of Texas at Austin, Austin, Texas 78713,4
Howard Hughes Medical Institute, Baltimore, Maryland 212055
Received 23 March 2006/
Accepted 19 April 2006
Antiretroviral therapy can reduce human immunodeficiency virus type 1 (HIV-1) viremia to below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However, latent HIV-1 persists in resting CD4+ T cells, and low residual levels of free virus are found in the plasma. Limited characterization of this residual viremia has been done because of the low number of virions per sample. Using intensive sampling, we analyzed residual viremia and compared these viruses to latent proviruses in resting CD4+ T cells in peripheral blood. For each patient, we found some viruses in the plasma that were identical to viruses in resting CD4+ T cells by pol gene sequencing. However, in a majority of patients, the most common viruses in the plasma were rarely found in resting CD4+ T cells even when the resting cell compartment was analyzed with assays that detect replication-competent viruses. Despite the large diversity of pol sequences in resting CD4+ T cells, the residual viremia was dominated by a homogeneous population of viruses with identical pol sequences. In the most extensively studied case, a predominant plasma sequence was also found in analysis of the env gene, and linkage by long-distance reverse transcriptase PCR established that these predominant plasma sequences represented a single predominant plasma virus clone. The predominant plasma clones were released for months to years without evident sequence change. Thus, in some patients on antiretroviral therapy, the major mechanism for residual viremia involves prolonged production of a small number of viral clones without evident evolution, possibly by cells other than circulating CD4+ T cells.
* Corresponding author. Mailing address: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205. Phone: (410) 955-2958. Fax: (443) 287-6218. E-mail: rsiliciano{at}jhmi.edu.
Supplemental material for this article may be found at http://jvi.asm.org/.
These authors contributed equally to this work.
Journal of Virology, July 2006, p. 6441-6457, Vol. 80, No. 13
0022-538X/06/$08.00+0 doi:10.1128/JVI.00591-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
(2008). Decay dynamics of HIV-1 depend on the inhibited stages of the viral life cycle. Proc. Natl. Acad. Sci. USA
105: 4832-4837
-
Palmer, S., Maldarelli, F., Wiegand, A., Bernstein, B., Hanna, G. J., Brun, S. C., Kempf, D. J., Mellors, J. W., Coffin, J. M., King, M. S.
(2008). Low-level viremia persists for at least 7 years in patients on suppressive antiretroviral therapy. Proc. Natl. Acad. Sci. USA
105: 3879-3884
[Abstract]
[Full Text]
-
DeGottardi, M. Q., Lew, S. K., Piatak, M. Jr., Jia, B., Feng, Y., Lee, S. J., Brenchley, J. M., Douek, D. C., Kodama, T., Lifson, J. D., Evans, D. T.
(2008). Comparison of Plasma Viremia and Antibody Responses in Macaques Inoculated with Envelope Variants of Single-Cycle Simian Immunodeficiency Virus Differing in Infectivity and Cellular Tropism. J. Virol.
82: 321-334
[Abstract]
[Full Text]
-
Ambrose, Z., Palmer, S., Boltz, V. F., Kearney, M., Larsen, K., Polacino, P., Flanary, L., Oswald, K., Piatak, M. Jr., Smedley, J., Shao, W., Bischofberger, N., Maldarelli, F., Kimata, J. T., Mellors, J. W., Hu, S.-L., Coffin, J. M., Lifson, J. D., KewalRamani, V. N.
(2007). Suppression of Viremia and Evolution of Human Immunodeficiency Virus Type 1 Drug Resistance in a Macaque Model for Antiretroviral Therapy. J. Virol.
81: 12145-12155
[Abstract]
[Full Text]
-
Kaiser, P., Joos, B., Niederost, B., Weber, R., Gunthard, H. F., Fischer, M., the Swiss HIV Cohort Study,
(2007). Productive Human Immunodeficiency Virus Type 1 Infection in Peripheral Blood Predominantly Takes Place in CD4/CD8 Double-Negative T Lymphocytes. J. Virol.
81: 9693-9706
[Abstract]
[Full Text]
-
McMahon, M. A., Jilek, B. L., Brennan, T. P., Shen, L., Zhou, Y., Wind-Rotolo, M., Xing, S., Bhat, S., Hale, B., Hegarty, R., Chong, C. R., Liu, J. O., Siliciano, R. F., Thio, C. L.
(2007). The HBV Drug Entecavir -- Effects on HIV-1 Replication and Resistance. NEJM
356: 2614-2621
[Abstract]
[Full Text]
-
Sundstrom, J. B., Ellis, J. E., Hair, G. A., Kirshenbaum, A. S., Metcalfe, D. D., Yi, H., Cardona, A. C., Lindsay, M. K., Ansari, A. A.
(2007). Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood
109: 5293-5300
[Abstract]
[Full Text]
-
Wojcechowskyj, J. A., Yant, L. J., Wiseman, R. W., O'Connor, S. L., O'Connor, D. H.
(2007). Control of Simian Immunodeficiency Virus SIVmac239 Is Not Predicted by Inheritance of Mamu-B*17-Containing Haplotypes. J. Virol.
81: 406-410
[Abstract]
[Full Text]
Copyright © 2006 by the American Society for Microbiology. All rights reserved.